Long before Meera Garcia had a company to run, she had stuffed animals to repair. As a child, she would take them apart and sew them back together. She pretended to give shots. The story, which she told in a 2021 interview, sounds like the neat origin myth of a future physician. Look again and it also reveals something more durable: a desire to inspect a system, understand its parts and put it back together with greater intention.
That instinct has followed Garcia through a career that keeps widening its field of view. She studied biology and psychology at Case Western Reserve University, earned her medical degree at Duke, trained in obstetrics and gynecology at Emory, practiced and taught, then moved into increasingly broad operational roles. At NewYork-Presbyterian Hudson Valley Hospital, she served as a division chief. At NewYork-Presbyterian Medical Group Hudson Valley, she was a regional director. In 2021, she joined Advantia Health as chief medical officer and also led medical work at Pacify.
Each role changed the unit of work. A conversation became a team. A team became a regional service. A regional service became a multi-state organization. Then Garcia made the unit smaller and riskier: a startup with only a handful of people and a piece of university research that had to become a product.
The beginner in the CEO chair
Lantern Laboratory grew from technology developed in the Columbia University lab of Paul Garcia, a physician-scientist and Meera's husband. The company is developing a medical-device platform that interprets electrical brain signals to give clinicians more information as they make time-sensitive medication decisions. Paul brought the research. Meera became the co-founder and CEO responsible for turning that research into an organization.
The arrangement contains all the raw material for an awkward family-business comedy: spouses, science, licensing and the stress of an early-stage company. Yet the public version of their collaboration is unusually clear. Paul is the inventor and scientific co-founder. Meera is the operator who translates a clinical insight into a company that partners, funders and future customers can understand.
She did not pretend the translation came naturally. In a 2023 pitch video, Garcia said she did not have much business or management experience and had realized that the scientific and technology side of the company needed more insight into strategy and business development. On Columbia's Columbia Invents podcast, she described learning what it took to launch a startup and navigating the experience of being a female CEO in a male-dominated field.
“We need to use language well, mindfully and for a purpose.”Meera Garcia, on why words matter
This is the part of the founder story that gets edited out most often. Expertise in a problem does not automatically include expertise in building a business around it. The cap table does not care how many years someone spent in a hospital. A product roadmap does not assemble itself because the science is promising. Garcia's useful move was to name the gap, then build a curriculum around it.
There is another reason the admission carries weight. Senior people are usually rewarded for projecting continuity: each new role is presented as the inevitable result of everything that came before. Garcia chose a more credible story. Her clinical experience gave her a map of the problem, but it did not give her every tool needed to finance, position and grow a company. By separating what transferred from what had to be learned, she turned a vague transition into a list of skills. That is founder work in its least theatrical form. A weakness becomes a syllabus. A missing relationship becomes a meeting. A difficult question becomes the next version of the pitch. The posture is less about confidence than calibration, knowing which judgment has been earned and which judgment still needs evidence.
An accelerator is a room full of translations
In 2023, Garcia joined Springboard Enterprises' Life Sciences Innovation program. Lantern then entered the National Institute on Aging's Start-Up Challenge and Accelerator, a program built to help science-driven teams test their commercial case. The company became one of six winners and received a $60,000 cash award. In the following program year, Lantern was selected for Creative Destruction Lab's Neuro stream in Toronto and graduated with the 2024/25 cohort.
The sequence matters more than any badge. Each program forced the same idea through a different filter. A scientist asks whether a signal is real. A clinician asks whether it is useful at the point of decision. An operator asks how it fits into a workflow. An investor asks whether the market can support a company. A founder has to hold all four questions at once without allowing one answer to impersonate another.
A career built by adding languages
Garcia later made that last line literal. Her public LinkedIn activity records that she completed an MBA at the University of Michigan's Ross School of Business after two years of study. For someone already carrying the titles MD, FACOG, CEO and CMO, the degree is less a credential grab than a statement about how she approaches unfamiliar terrain. She collects frameworks. She enters rooms where her existing authority cannot do the learning for her.
The operating system is language
Garcia's sharpest management lesson hides inside a pet peeve. Asked what bothered her, she named punctuation, grammar, syntax and spelling. People write emails, texts and spreadsheets all day, she explained, and giving language respect says something. She compared language to fire - an extraordinary human tool that needs to be used safely and wisely.
The answer is funny because it is precise, and revealing because it connects her worlds. Clinical practice depends on information passing cleanly between people. An executive depends on priorities surviving a trip through the org chart. A startup depends on an idea crossing from the lab to the pitch deck to the product plan without losing its meaning. In each setting, unclear language becomes operational debt.
Treat writing as part of the product. Before asking a team to move faster, make the sentence describing the destination impossible to misunderstand.
Her career offers evidence that she sees leadership as translation rather than proclamation. When she moved from NewYork-Presbyterian to Advantia, she described wanting to work in an active environment that was transforming care. She talked about leadership moving both top down and bottom up. Later, at Mother Goose Health, where she became chief medical officer in October 2024, her stated focus returned to the same theme: strategy must meet people where the system actually touches them.
That role also shows that Garcia has not traded operating responsibility for founder identity. She holds both. At Mother Goose, she shapes medical strategy for a growing platform. At Lantern, she is building the company around a distinct monitoring technology. One job gives her the view from inside a scaling organization. The other requires her to create the organization itself.
A career of widening circles
There are personal clues along the route. Garcia's first job was bagging groceries at a Kroger in Ohio during high school. She has two daughters. She and Paul once turned New York into a hiking trail, walking from Columbia to Tribeca, a route she estimated at about 12 miles. The details keep the résumé from becoming a clean, bloodless escalation of titles. A person who can move from grocery aisles to medical school to executive meetings can still take the long way downtown on foot.
The early stuffed-animal story lands differently after all of this. Taking something apart is easy. Putting it together so that it works again requires patience, an eye for seams and a willingness to admit which piece belongs where. Garcia has spent her career increasing the complexity of the object on the table.
Lantern remains an early-stage company. Its public website is sparse, and its visible milestones are the measured kind: a license, a prize, a cohort, a pitch, a team. That modesty is useful. It leaves the story where company-building actually happens - between evidence and adoption, where credibility is accumulated in small units and no title can skip the work.
Garcia's advantage is not simply that she knows medicine or now knows business. It is that she has practiced crossing the border between them. Her trajectory suggests a model of ambition built less around reinvention than accumulation. The physician is still present in the operator. The operator is present in the founder. The founder went back to school. Each identity gives the next one a better question to ask.
The operator who can return to student mode has an edge. Expertise compounds fastest when it stays teachable.
There will always be more signals than one person can read. Garcia's career is an argument for getting better at choosing which ones matter, then building a team capable of hearing the rest.